Sean joined GTCR in 2001 and is currently a Managing Director of the firm. He was previously a consultant with The Boston Consulting Group. Sean holds an MBA from the Wharton School at the University of Pennsylvania, a BE from the Thayer School of Engineering at Dartmouth College and an AB in Engineering Sciences from Dartmouth College.
Sean currently is a director of Cedar Gate Technologies, Cole-Parmer, Cord Blood Registry, Correct Care Solutions, Maravai Life Sciences, Rx30 and Sterigenics. He was instrumental in GTCR’s past investments in Devicor Medical Products, Graceway Pharmaceuticals and Ovation Pharmaceuticals.